← Leaderboards
Luiz E Bermudez
California Pacific Med Ctr Res Institute
$7,151,777
Attributed
$7,823,280
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $617.9K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,823,280 · 7
By mechanism
R01$5,621,009 · 2
R44$972,649 · 1
R21$800,078 · 2
R43$277,768 · 1
R03$151,776 · 1
Top collaborators
- James D Blanchard3 shared
- Igor Gonda1 shared
Others in their field
Top investigators on “Mycobacterium Avium”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Robert Turner Schooley · University Of Colorado Denver$42,720,862
- Robert L. Murphy · Northwestern University$10,922,423
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$10,260,229
- Richard C. Reichman · University Of Rochester$9,727,852
- Michael Marcel Lederman · Case Western Reserve University$9,709,022
Research focus
Mycobacterium AviumMacrophageVirulenceBacteriaGenesFutureBaseInfectionMycobacterialBacterial ProteinsIntestinal MucosaEpithelial CellsGene Expression RegulationEnvironmentCellsAcquired Immunodeficiency SyndromeIntestinesPathogenPathway InteractionsGenus MycobacteriumKillingsIn VitroLaboratory MouseMycobacterium Smegmatis
Grant awards (28)
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$486,050
R44 · FY2018 · AI
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$486,599
R44 · FY2017 · AI
Strategy for anti-tuberculosis therapy$182,500
R21 · FY2015 · AI · contact PI
Genes associated with Mycobacterium avium pathogenesis$361,845
R01 · FY2014 · AI · contact PI
Strategy for anti-tuberculosis therapy$219,000
R21 · FY2014 · AI · contact PI
Genes associated with Mycobacterium avium pathogenesis$340,134
R01 · FY2013 · AI · contact PI
In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Myc$277,768
R43 · FY2013 · AI
Genes associated with Mycobacterium avium pathogenesis$361,845
R01 · FY2012 · AI · contact PI
Genes associated with Mycobacterium avium pathogenesis$361,845
R01 · FY2011 · AI · contact PI
Genes associated with Mycobacterium avium pathogenesis$365,500
R01 · FY2010 · AI · contact PI
Genes Associated with Mycobacterium avium Pathogenesis$305,107
R01 · FY2008 · AI · contact PI
Post Translation Regulation in Mycobacteria$179,278
R21 · FY2008 · AI · contact PI
Genes Associated with Mycobacterium avium Pathogenesis$311,728
R01 · FY2007 · AI · contact PI
Post Translation Regulation in Mycobacteria$219,300
R21 · FY2007 · AI · contact PI
Genes Associated with M .avium Pathogenesis$321,748
R01 · FY2006 · AI · contact PI
Genes Associated with M .avium Pathogenesis$330,198
R01 · FY2005 · AI
Genes Associated with M .avium Pathogenesis$341,300
R01 · FY2004 · AI
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES$325,809
R01 · FY2003 · AI
GENES ASSOCIATED WITH M AVIUM PATHOGENESIS$294,972
R01 · FY2002 · AI
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES$234,422
R01 · FY2002 · AI
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES$89,602
R01 · FY2002 · AI
Target for Mefloquine in Mycobacteria$39,111
R03 · FY2002 · AI
Target for Mefloquine in Mycobacteria$34,815
R03 · FY2002 · AI
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES$330,260
R01 · FY2001 · AI
GENES ASSOCIATED WITH M AVIUM PATHOGENESIS$294,352
R01 · FY2001 · AI
Target for Mefloquine in Mycobacteria$77,850
R03 · FY2001 · AI
MYCOBACTERIAL ENVIRONMENT WITHIN MACROPHAGES$364,565
R01 · FY2000 · AI
GENES ASSOCIATED WITH M AVIUM PATHOGENESIS$285,777
R01 · FY2000 · AI